AGM/EGMMay 20, 2026, 05:36 PM
Treace Medical Stockholders Elect Directors, Approve Comp, Ratify Auditor
AI Summary
Treace Medical Concepts, Inc. held its 2026 Annual Meeting of Stockholders on May 19, 2026. Stockholders elected three Class II directors to serve three-year terms. Additionally, they approved, on an advisory basis, the compensation of the company's named executive officers and ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Key Highlights
- Stockholders elected Lance A. Berry, Elizabeth S. Hanna, and Jane E. Kiernan as Class II directors for a three-year term.
- Lance A. Berry received 33,804,407 votes For, Elizabeth S. Hanna 30,856,965 votes For, and Jane E. Kiernan 33,587,226 votes For.
- Stockholders approved, on an advisory basis, executive compensation with 32,785,505 votes For.
- Stockholders ratified Grant Thornton LLP as the independent registered public accounting firm for 2026 with 47,885,305 votes For.
Price Impact
More from TMCI